Quarterly and annual results disclosed under 8-K Item 2.02.
Amylyx Pharmaceuticals, Inc. reported first quarter ended March 31, 2026 results: net income Net loss for the three months ended March 31, 2026 was $41.3 million, or $0.37 per share, EPS $0.37 per share.
“Net loss for the three months ended March 31, 2026 was $41.3 million, or $0.37 per share, compared to net loss of $35.9 million, or $0.42 per share, for the same period in 2025.”
Organogenesis Holdings Inc. reported first quarter ended March 31, 2026 results: revenue $36.3 million, net income Net loss of $53.2 million, EPS $(0.44) per share. Guidance lowered.
“Net revenue of $36.3 million for the first quarter of 2026”
Phunware, Inc. reported first quarter ended March 31, 2026 results: revenue $0.5 million, net income $3.2 million, EPS ($0.16).
“Net revenue decreased 21% to $0.5 million in Q1 2026, as compared to $0.7 million in Q1 2025. • Gross margin improved to 70.8% in Q1 2026, as compared to 52.2% in Q1 2025. • Net loss improved to $3.2 million in Q1 2026, as compared to a net loss of $3.7 million in the previous year period. • Net loss per basic and diluted share was ($0.16) in Q1 2026, as compared to ($0.18) per basic and diluted share in Q1 2025.”
US Foods Holding Corp. reported financial results for fiscal first quarter ended March 28, 2026.
“On May 7, 2026, US Foods Holding Corp. issued a press release announcing its financial results for the fiscal first quarter ended March 28, 2026.”
Cardlytics, Inc. reported Q2 2026 results: revenue $35.0 - $40.0 million. Guidance initiated.
“Cardlytics anticipates Billings, Revenue, Adjusted Contribution and Adjusted EBITDA to be in the following ranges (in millions, except for percentage change rates): Q2 2026 Guidance YoY Change Billings (1) $61.0 - $67.0 (38%) - (32%) Revenue $35.0 - $40.0 (40%) - (31%) Adjusted Contribution (2) $20.0 - $23.0 (36%) - (27%) Adjusted EBITDA (2) ($2.7) - $1.3 ($5.7) - ($1.7)”
Cardlytics, Inc. reported Q1 2026 results: revenue $34.3 million, net income $(4.5) million, EPS $(0.08) per diluted share.
“Revenue was $34.3 million, a decrease of 39% year-over-year compared to $56.4 million in the first quarter of 2025. • Billings, a non-GAAP metric, was $58.1 million, a decrease of 37% year-over-year compared to $92.1 million in the first quarter of 2025. • Adjusted Contribution, a non-GAAP metric, was $19.7 million, a decrease of 28% year-over-year compared to $27.3 million in the first quarter of 2025. • Net Loss was $(4.5) million, or $(0.08) per diluted share, based on 54.9 million fully diluted weighted-average common shares, compared to a Net Loss of $(13.3) million, or $(0.26) per diluted share, based on 51.9 million fully diluted weighted-average common shares in the first quarter of 2025.”
Quoin Pharmaceuticals, Ltd. reported preliminary financial results for first quarter 2026.
“On May 7, 2026 Quoin Pharmaceuticals Ltd. (the “Company”) announced its first quarter 2026 financial results.”
Trade Desk, Inc. reported first quarter ended March 31, 2026 results: revenue $689 million, net income $40 million, EPS $0.08. Guidance reaffirmed.
“buyers of advertising, today announced financial results for its first quarter ended March 31, 2026. “Q1 was another strong quarter for The Trade Desk, with revenue growing to $689 million, representing 12% year-over-year growth,” said Jeff Green, CEO and Co-Founder of The Trade Desk. “We’re encouraged by the impact of the strategic upgrades we’ve been making”
Enliven Therapeutics, Inc. reported the first quarter ended March 31, 2026 results: net income $23.6 million.
“Enliven reported a net loss of $23.6 million for the first quarter of 2026”
Absci Corp reported first quarter ended March 31, 2026 results: revenue $0.2 million.
“Revenue was $0.2 million for the three months ended March 31, 2026, compared to $1.2 million for the three months ended March 31, 2025.”
VALVOLINE INC updated its second quarter ended March 31, 2026 guidance (raised).
“On May 7, 2026, Valvoline Inc. (“Valvoline”) issued a press release ("Earnings Release") announcing its financial results for the second quarter ended March 31, 2026.”
International Seaways, Inc. reported first quarter 2026 results: revenue $325 million, net income $286 million, EPS $5.75 per diluted share.
“spot earnings that increased an average of approximately $30,000 per day across the fleet and an increase in gains on vessel sales. Shipping revenues for the first quarter were $325 million, compared to $183 million for the first quarter of 2025. Consolidated TCE revenues (1) for the first quarter were $317 million, compared to $178 million for the first quarter of”
Coinbase Global, Inc. reported financial results for the quarter ended March 31, 2026.
“On May 7, 2026 , Coinbase Global, Inc. (the “Company”) published a presentation related to its financial results for the quarter ended March 31, 2026”
ACM Research, Inc. reported first quarter ended March 31, 2026 results: revenue $231,263, net income $17,307, EPS $0.24. Guidance reaffirmed.
“requirements across a broad and expanding global customer base.” Three Months Ended March 31, GAAP Non-GAAP(1) 2026 2025 2026 2025 (dollars in thousands, except EPS) Revenue $ 231,263 $ 172,347 $ 231,263 $ 172,347 Gross margin 46.4 % 47.9 % 46.5 % 48.2 % Income from operations $ 36,177 $ 25,777 $ 41,798 $ 35,594 Net income attributable to ACM Research, Inc. $”
Shattuck Labs, Inc. reported first quarter ended March 31, 2026 results: net income $14.8 million for the quarter ended March 31, 2026, or $0.13 per basic and diluted share, EPS $0.13 per basic and diluted share.
“Shattuck Labs Reports First Quarter 2026 Financial Results”
Tectonic Therapeutic, Inc. reported financial results for the first quarter ended March 31, 2026.
“On May 7, 2026, Tectonic Therapeutic, Inc. announced its financial results for the quarter ended March 31, 2026 and provided a general business update.”
Varex Imaging Corp reported third quarter of fiscal year 2026 results: revenue between $210 million and $225 million, EPS Non-GAAP net earnings per diluted share is expected to be between $0.15 and $0.30. Guidance initiated.
“Guidance for the third quarter of fiscal year 2026 is as follows: • Revenues are expected to be between $210 million and $225 million • Non-GAAP net earnings per diluted share is expected to be between $0.15 and $0.30”
Varex Imaging Corp reported second quarter fiscal year 2026 results: revenue $216 million, EPS GAAP net loss $0.19 per diluted share | Non-GAAP net income* $0.21 per diluted share. Guidance reaffirmed.
“CITY, May 7, 2026 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter fiscal year 2026. Q2FY26 Summary • Revenues $216 million • GAAP gross margin 34% | Non-GAAP gross margin* 34% • GAAP operating margin 7% | Non-GAAP operating margin* 9% • GAAP net loss $0.19 per diluted share | Non-GAAP net income*”
Cars.com Inc. reported first quarter ended March 31, 2026 results: revenue $180.2 million, net income $5.0 million, EPS $0.08 per diluted share.
“and is incorporated herein by reference. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Cars.com Reports First Quarter 2026 Results • Revenue grew in line with guidance to $180.2 million, up 1% year-over-year • Net income increased to $5.0 million compared to net loss of ($2.0) million in the prior year • Adjusted EBITDA grew to $51.0 million, up 1%”
DXC Technology Co reported full fiscal year 2027 results: revenue in the range of $12.11 billion to $12.35 billion, EPS in the range of $2.40 to $2.90. Guidance initiated.
“Total revenue in the range of $12.11 billion to $12.35 billion, a decline of 5.0% to 3.0% year-over-year on an organic basis.”
DXC Technology Co reported First quarter fiscal year 2027 and full fiscal year 2027 results: revenue in the range of $2.97 billion to $3.00 billion, EPS ~$0.40. Guidance initiated.
“Total revenue in the range of $2.97 billion to $3.00 billion, a decline of 7.5% to 6.5% year-over-year on an organic basis.”
DXC Technology Co reported full fiscal year 2026 results: revenue $12.64 billion, EPS $0.10.
“Total revenue was $12.64 billion, down 1.8% year-over-year, down 4.8% on an organic basis.”
DXC Technology Co reported the fourth quarter and full year of fiscal 2026 ended March 31, 2026 results: revenue $3.13 billion, EPS $(0.84).
“forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- DXC Technology Reports Fourth Quarter and Full Fiscal Year 2026 Results • Total revenue for Q4 FY26 of $3.13 billion, down 1.2% YoY, down 6.6% on an organic basis (1) • Q4 FY26 Bookings of $3.3 billion, book to bill ratio of 1.07x • Q4 FY26 EBIT margin of (1.2)%, and adjusted EBIT (2) margin of”
Entrada Therapeutics, Inc. reported financial results for the first quarter ended March 31, 2026.
“On May 7, 2026, Entrada Therapeutics, Inc. (the “Company”) announced its financial results for the quarter ended March 31, 2026 and other corporate updates.”
Kinetik Holdings Inc. reported the quarter ended March 31, 2026 results: net income $5.1 million. Guidance reaffirmed.
“For the three months ended March 31, 2026, Kinetik reported net loss including noncontrolling interest of $5.1 million, Adjusted EBITDA 1 of $251.2 million, Distributable Cash Flow 1 of $180.8 million, and Free Cash Flow 1 of $101.4 million.”
Vistra Corp. updated its fiscal year 2026 guidance (reaffirmed).
“Reaffirmed 2026 Ongoing Operations Adjusted EBITDA 1 and Ongoing Operations Adjusted FCFbG 1 guidance ranges of $6.8 billion to $7.6 billion and $3.925 billion to $4.725 billion, respectively.”
Vistra Corp. reported quarter ended March 31, 2025 results: net income $(268) million.
“Net income (loss) $ 1,029 $ (268)”
Vistra Corp. reported quarter ended March 31, 2026 results: net income $1,029 million. Guidance reaffirmed.
“For the quarter ended March 31, 2026, Vistra reported Net Income of $1,029 million and Ongoing Operations Adjusted EBITDA 1 of $1,494 million.”
Once Upon a Farm, PBC reported Full year 2026 results: revenue $313 million to $323 million. Guidance raised.
“Raising 2026 net sales outlook to $313 million to $323 million”
Once Upon a Farm, PBC reported the first quarter ended March 31, 2026 results: revenue $72.7 million, net income $15.8 million.
“First Quarter 2026 Financial Highlights Compared to Prior Year Period • Net sales increased 43.7% to $72.7 million • Gross margin of 40.8% compared to 37.7% • Net loss of $15.8 million compared to a net loss of $19.5 million”
Cactus, Inc. reported first quarter ended March 31, 2026 results: revenue $388.3 million, net income $40.2 million, EPS diluted loss per Class A share of $0.70.
“1, 2026, Cactus closed on its previously announced acquisition of a majority interest in Baker Hughes' Surface Pressure Control business (“Cactus International”); • Revenue of $388.3 million and operating income of $49.5 million; • Net income of $40.2 million and diluted loss per Class A share of $0.70; • Adjusted net income (1) of $56.2 million and diluted earnings”
Black Diamond Therapeutics, Inc. reported first quarter ended March 31, 2026 results: net income $9.0 million.
“Net loss for the first quarter of 2026 was $9.0 million, as compared to net income of $56.5 million for the same period in 2025.”
Optimum Communications, Inc. reported the quarter ended March 31, 2026 results: revenue $2.07 billion, net income ($2,884.1) million, EPS ($6.10)/share on a diluted basis.
“structure, are the right foundation for creating durable long-term value for our customers, our employees, and our shareholders." First Quarter 2026 Overview • Total revenue of $2.07 billion in Q1 2026 (-4.0% year over year) • Residential revenue of $1.56 billion in Q1 2026 (-6.5% year over year) ◦ Residential average revenue per user (ARPU) (1) $132.32 (-1.2% year”
Korro Bio, Inc. reported first quarter ended March 31, 2026 results: net income $19.6 million.
“Korro’s net loss was $19.6 million for the three months ended March 31, 2026”
Bluejay Diagnostics, Inc. reported fiscal quarter ended March 31, 2026 results: net income approximately $1.9 million.
“As of March 31, 2026, Bluejay reported cash and cash equivalents of approximately $3.7 million. The Company reported a net loss of approximately $1.9 million for the first quarter of 2026, compared to approximately $1.9 million for the same period in 2025.”
Zai Lab Ltd reported the first quarter of 2026 results: revenue $99.6 million, net income Net loss was $51.0 million, EPS loss per ADS of $0.46.
“forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Zai Lab Announces First Quarter 2026 Financial Results and Recent Corporate Updates – Total revenues of $99.6 million for the first quarter of 2026, reflecting anticipated first-quarter dynamics, including certain competitive impacts for ZEJULA and pricing adjustment related to NRDL renewal for”
Funko, Inc. reported 2026 Second Quarter results: revenue Net sales $195 million to $205 million, up 1% to 6% compared with Q2 2025. Guidance initiated.
“2026 Second Quarter Net sales $195 million to $205 million, up 1% to 6% compared with Q2 2025 Gross margin % ~42% to 44% Adjusted EBITDA* $5 million to $10 million”
Funko, Inc. reported 2026 Full Year results: revenue Net Sales flat to up 3% vs 2025. Guidance reaffirmed.
“Current Outlook 2026 Full Year Net Sales flat to up 3% vs 2025 Gross Margin % ~41% to 43% Adjusted EBITDA* $70 million to $80 million”
Funko, Inc. reported First Quarter 2026 results: revenue Net sales were $200.9 million, net income Net loss was $18.1 million, EPS $0.33 per share.
“Net sales were $200.9 million compared with $190.7 million • Gross profit was $88.8 million, equal to gross margin of 44.2%, compared with $76.9 million, equal to gross margin of 40.3% • SG&A expenses were $83.7 million compared with $84.8 million • Net loss was $18.1 million, or $0.33 per share, compared with $28.1 million, or $0.52 per share”
Edgewise Therapeutics, Inc. reported financial results for first quarter of 2026.
“Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the first quarter of 2026 and recent business highlights.”
Core Natural Resources, Inc. reported first quarter of 2026 results: revenue $1.1 billion, net income $21.0 million, EPS $0.41 per diluted share.
“Core Natural Resources, Inc. (NYSE: CNR) (“Core” or the “company”) reported net income of $21.0 million, or $0.41 per diluted share, in the first quarter of 2026. Additionally, Core reported adjusted EBITDA 1 of $179.9 million in the quarter. Revenues totaled $1.1 billion in Q1.”
Evergy, Inc. reported first quarter ended March 31, 2026 results: net income $151.5 million, EPS $0.64 per share. Guidance reaffirmed.
“Evergy, Inc. (NASDAQ: EVRG) today announced first quarter 2026 GAAP earnings of $151.5 million, or $0.64 per share”
Liberty Latin America Ltd. reported financial results for the three months ended March 31, 2026.
“Liberty Latin America Ltd. (“Liberty Latin America” or “LLA”) (NASDAQ: LILA and LILAK, OTC Link: LILAB) today announced its financial and operating results for the three months (“Q1”) ended March 31, 2026.”
Denali Therapeutics Inc. reported financial results for the first quarter ended March 31, 2026.
“On May 7, 2026, Denali Therapeutics Inc. (the "Company") issued a press release announcing its financial results for the first quarter ended March 31, 2026.”
Red Violet, Inc. reported first quarter ended March 31, 2026 results: revenue $25.8 million, net income $4.4 million, EPS $0.31 and $0.30 per basic and diluted share.
“red violet Announces First Quarter 2026 Financial Results Revenue Increases 17% to a Record $25.8 Million; Net Income Increases 28% to $4.4 Million”
Amneal Pharmaceuticals, Inc. reported first quarter ended March 31, 2026 results: revenue $723 million, net income $62 million, EPS $0.19. Guidance reaffirmed.
“AMNEAL REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS ‒ Q1 2026 Net Revenue of $723 million; GAAP Net Income of $62 million; Diluted Income per Share of $0.19 ‒”
Scholar Rock Holding Corp reported the quarter ended March 31, 2026 results: net income $105.5 million, EPS $0.83.
“Scholar Rock reported a net loss of $105.5 million, including stock-based compensation of $18.2 million, for the quarter ended March 31, 2026, compared to a net loss of $74.7 million, including stock-based compensation of $13.4 million, for the quarter ended March 31, 2025. Net loss per common share was $0.83 for the quarter ended March 31, 2026, compared to $0.67 per common share for the quarter ended March 31, 2025.”
i3 Verticals, Inc. reported six months ended March 31, 2026 results: revenue $110.2 million, net income $3.3 million, EPS $0.09.
“Revenue from continuing operations 1 for the six months ended March 31, 2026, was $110.2 million, an increase of 3.6% over the prior year's first six months.”
i3 Verticals, Inc. reported fiscal second quarter ended March 31, 2026 results: revenue $57.5 million, net income $2.2 million, EPS $0.07.
“Second quarter revenue from continuing operations 1 was $57.5 million, an increase of 6.2% over the prior year's second quarter.”
Blackstone Secured Lending Fund reported financial results for first quarter ended March 31, 2026.
“On May 7, 2026, Blackstone Secured Lending Fund issued a press release and detailed presentation announcing its financial results for the first quarter ended March 31, 2026.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.